SATKARTAR (SATKARTAR) fundamentals
SATKARTAR is a listed company, part of the Pharmaceuticals sector, listed on the NSE as SATKARTAR (ISIN INE0NB801022). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What SATKARTAR does
Sat Kartar Shopping Ltd is an India-based company, which manufactures, curates, and makes available online, authentic ayurvedic products in India. The Company’s products includes Ayush Total Health, Liv Muztang Plus, Shilajit Imli Prash, Sampoorna Arogya Herbal Tea, SK Turbo Treats, Vajra 44, Liv Muztang Capsule, Herbo 365 Oil, Addiction Killer, Adivasi Hair Oil, Aadved Bhringraj Oil, Arshoqit, Herbo 365 Capsule, Piles End, Ayush 82 Aadved, Piles Stop, Kaama Gold, Liv Muztang Healthy Shots, Ayush for Women, Addiction Killer Liquid, Liver Care, Nasha Free, Nasha Nivaran, Madhu Nivarani, Ortho Veda Oil, Power Rootz SSS Formulae, Jaam e Ishq, Gaiso Mukt, Ultimate Hammer, Diabaquit, Poshan Plus, Nari Jeevan Jyoti, Stones Veda, Ayush for Men, Ayush Kavach, Sk Pilo, Extra Time, Golden Power, Vayu Shuddhi, Sandy Rx, Ayush Kwath, Aadved Slim Veda, Asthi Urja, Dhurandar Joint Pain Oil, Arokkiyam, Aadved Sleep, Dr Piles Free, and Dr Madhu Amrit.
Valuation and market data
| Last close | ₹147.00 |
|---|---|
| Market capitalisation | ₹231 crore |
| Enterprise value | ₹211 crore |
| P/E (TTM) | 0.00 |
| Price to book | 3.42 |
| Price to sales (TTM) | 0.00 |
| Book value per share | ₹42.93 |
| Dividend yield | 47.62% |
| Sector | Pharmaceuticals |
| Industry | — |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹203 crore | ₹23 crore | ₹17 crore | 10.86 |
| Mar 2025 | ₹164 crore | ₹13 crore | ₹10 crore | 7.37 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Mar 2026:
| Promoters | 63.6% |
|---|---|
| Foreign institutions (FII) | 0.1% |
| Mutual funds | 0.0% |
| Other domestic institutions | 2.3% |
| Retail and others | 34.0% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.